EHRA Premium Access

Thromboembolic risk in patients with atrial fibrillation and valvular heart disease according to the EHRA Type 2 definition: beyond mitral stenosis and mechanical prosthetic heart valve - Discussion

Topic: Stroke in Atrial Fibrillation

Congress Presentation

About the speaker

Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
61 presentations
11 followers

10 more presentations in this session

Uninterrupted edoxaban versus vitamin k antagonists for ablation of atrial fibrillation:the ELIMINATE-AF Trial

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Thumbnail

ELIMINATE-AF Trial - Discussion

Speaker: Associate Professor T. Potpara (Belgrade, RS)

Thumbnail

Internal vs. external electrical cardioversion of atrial arrhythmias in patients with an implantable cardioverter-defibrillator: a randomised controlled clinical trial

Speaker: Doctor J. Luker (Cologne, DE)

Thumbnail

Internal vs. external electrical cardioversion of atrial arrhythmias in patients with an implantable cardioverter-defibrillator: a randomised controlled clinical trial - Discussion

Speaker: Professor I. Van Gelder (Groningen, NL)

Thumbnail

Thromboembolic risk in patients with atrial fibrillation and valvular heart disease according to the EHRA Type 2 definition: beyond mitral stenosis and mechanical prosthetic heart valve.

Speaker: Miss L. Melgaard (Aalborg, DK)

Thumbnail

Access the full session

Late-breaking trials 3

Speakers: Professor P. Kirchhof, Professor S. Hohnloser, Associate Professor T. Potpara, Doctor J. Luker, Professor I. Van Gelder...
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations